A detailed history of Pathstone Holdings, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 528,325 shares of MRK stock, worth $52 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
528,325
Previous 535,384 1.32%
Holding current value
$52 Million
Previous $66.3 Million 9.48%
% of portfolio
0.27%
Previous 0.3%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$111.15 - $128.97 $784,607 - $910,399
-7,059 Reduced 1.32%
528,325 $60 Million
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $909,311 - $976,591
-7,345 Reduced 1.35%
535,384 $66.3 Million
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $2.04 Million - $2.37 Million
17,990 Added 3.43%
542,729 $71.6 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $52.6 Million - $57.2 Million
524,739 New
524,739 $57.2 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $250B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.